Home > > > > > Report Detail

Global Injectable Anticoagulants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 12-Sep-2022
No. of pages: 102
Inquire Before Buying

The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).

In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Injectable Anticoagulants market is projected to reach US$ 7058.3 million by 2028 from an estimated US$ 6230.8 million in 2022, at a CAGR of 2.1% during 2023 and 2028.

Market competition is intense. Sanofi, Genentech (Roche), Boehringer Ingelheim and Pfizer, etc. are the leaders of the industry, with about 68% market shares.

North America is the largest consumption place, with a consumption market share nearly 34%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Injectable Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Injectable Anticoagulants.

The Injectable Anticoagulants market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Injectable Anticoagulants market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Injectable Anticoagulants companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Sanofi

- Genentech (Roche)

- Boehringer Ingelheim

- Pfizer

- The Medicines Company

- Aspen

- Otsuka

Product Type Insights

Global markets are presented by Injectable Anticoagulants type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Injectable Anticoagulants are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Injectable Anticoagulants Segment by Type

- Low-Molecular-Weight Heparin (LMWH)

- Direct Thrombin Inhibitor (DTI)

- Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Injectable Anticoagulants market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Injectable Anticoagulants market.

Injectable Anticoagulants Segment by Application

- VTE

- ACS/MI

- AF

- Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Injectable Anticoagulants market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Anticoagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Injectable Anticoagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Injectable Anticoagulants industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Anticoagulants.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Global Injectable Anticoagulants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Injectable Anticoagulants Product Introduction
1.2 Market by Type
1.2.1 Global Injectable Anticoagulants Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Low-Molecular-Weight Heparin (LMWH)
1.2.3 Direct Thrombin Inhibitor (DTI)
1.2.4 Others
1.3 Market by Application
1.3.1 Global Injectable Anticoagulants Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Injectable Anticoagulants Market Size Estimates and Forecasts
2.2 Injectable Anticoagulants Market Size by Region: 2022 Versus 2028
2.2.1 Global Injectable Anticoagulants Revenue by Region: 2017-2022
2.2.2 Global Injectable Anticoagulants Revenue Forecast by Region (2023-2028)
2.2.3 Global Injectable Anticoagulants Revenue Market Share by Region (2017-2028)
3 Global Injectable Anticoagulants by Company
3.1 Global Injectable Anticoagulants Revenue by Company (2017-2022)
3.2 Global Injectable Anticoagulants Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Injectable Anticoagulants Companies around the World: Ranking by Revenue
3.3.2 Global Injectable Anticoagulants Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Injectable Anticoagulants Companies Headquarters & Product Type
3.4.1 Injectable Anticoagulants Companies Headquarters
3.4.2 Global Injectable Anticoagulants Companies Product & Service
3.4.3 Date of International Companies Enter into Injectable Anticoagulants Market
3.5 Global Injectable Anticoagulants Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Sanofi
4.1.1 Sanofi Corporation Information
4.1.2 Sanofi Description, Business Overview
4.1.3 Sanofi Injectable Anticoagulants Products Offered
4.1.4 Sanofi Injectable Anticoagulants Revenue and Gross Margin (2017-2022)
4.1.5 Sanofi Injectable Anticoagulants Revenue by Product in 2021
4.1.6 Sanofi Injectable Anticoagulants Revenue by Application in 2021
4.1.7 Sanofi Injectable Anticoagulants Revenue by Geographic Area in 2021
4.1.8 Sanofi Recent Developments
4.2 Genentech (Roche)
4.2.1 Genentech (Roche) Corporation Information
4.2.2 Genentech (Roche) Description, Business Overview
4.2.3 Genentech (Roche) Injectable Anticoagulants Products Offered
4.2.4 Genentech (Roche) Injectable Anticoagulants Revenue and Gross Margin (2017-2022)
4.2.5 Genentech (Roche) Injectable Anticoagulants Revenue by Product in 2021
4.2.6 Genentech (Roche) Injectable Anticoagulants Revenue by Application in 2021
4.2.7 Genentech (Roche) Injectable Anticoagulants Revenue by Geographic Area in 2021
4.2.8 Genentech (Roche) Recent Developments
4.3 Boehringer Ingelheim
4.3.1 Boehringer Ingelheim Corporation Information
4.3.2 Boehringer Ingelheim Description, Business Overview
4.3.3 Boehringer Ingelheim Injectable Anticoagulants Products Offered
4.3.4 Boehringer Ingelheim Injectable Anticoagulants Revenue and Gross Margin (2017-2022)
4.3.5 Boehringer Ingelheim Injectable Anticoagulants Revenue by Product in 2021
4.3.6 Boehringer Ingelheim Injectable Anticoagulants Revenue by Application in 2021
4.3.7 Boehringer Ingelheim Injectable Anticoagulants Revenue by Geographic Area in 2021
4.3.8 Boehringer Ingelheim Recent Developments
4.4 Pfizer
4.4.1 Pfizer Corporation Information
4.4.2 Pfizer Description, Business Overview
4.4.3 Pfizer Injectable Anticoagulants Products Offered
4.4.4 Pfizer Injectable Anticoagulants Revenue and Gross Margin (2017-2022)
4.4.5 Pfizer Injectable Anticoagulants Revenue by Product in 2021
4.4.6 Pfizer Injectable Anticoagulants Revenue by Application in 2021
4.4.7 Pfizer Injectable Anticoagulants Revenue by Geographic Area in 2021
4.4.8 Pfizer Recent Developments
4.5 The Medicines Company
4.5.1 The Medicines Company Corporation Information
4.5.2 The Medicines Company Description, Business Overview
4.5.3 The Medicines Company Injectable Anticoagulants Products Offered
4.5.4 The Medicines Company Injectable Anticoagulants Revenue and Gross Margin (2017-2022)
4.5.5 The Medicines Company Injectable Anticoagulants Revenue by Product in 2021
4.5.6 The Medicines Company Injectable Anticoagulants Revenue by Application in 2021
4.5.7 The Medicines Company Injectable Anticoagulants Revenue by Geographic Area in 2021
4.5.8 The Medicines Company Recent Developments
4.6 Aspen
4.6.1 Aspen Corporation Information
4.6.2 Aspen Description, Business Overview
4.6.3 Aspen Injectable Anticoagulants Products Offered
4.6.4 Aspen Injectable Anticoagulants Revenue and Gross Margin (2017-2022)
4.6.5 Aspen Injectable Anticoagulants Revenue by Product in 2021
4.6.6 Aspen Injectable Anticoagulants Revenue by Application in 2021
4.6.7 Aspen Injectable Anticoagulants Revenue by Geographic Area in 2021
4.6.8 Aspen Recent Development
4.7 Otsuka
4.7.1 Otsuka Corporation Information
4.7.2 Otsuka Description, Business Overview
4.7.3 Otsuka Injectable Anticoagulants Products Offered
4.7.4 Otsuka Injectable Anticoagulants Revenue and Gross Margin (2017-2022)
4.7.5 Otsuka Injectable Anticoagulants Revenue by Product in 2021
4.7.6 Otsuka Injectable Anticoagulants Revenue by Application in 2021
4.7.7 Otsuka Injectable Anticoagulants Revenue by Geographic Area in 2021
4.7.8 Otsuka Recent Development
5 Breakdown Data by Type
5.1 Global Injectable Anticoagulants Revenue by Type (2017-2022)
5.2 Global Injectable Anticoagulants Revenue Forecast by Type (2023-2028)
5.3 Injectable Anticoagulants Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Injectable Anticoagulants Revenue by Application (2017-2022)
6.2 Global Injectable Anticoagulants Revenue Forecast by Application (2023-2028)
6.3 Injectable Anticoagulants Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Injectable Anticoagulants Market Size YoY Growth 2017-2028
7.2 North America Injectable Anticoagulants Market Facts & Figures by Country (2017-2028)
7.3 North America Injectable Anticoagulants Revenue by Type (2017-2022)
7.4 North America Injectable Anticoagulants Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Injectable Anticoagulants Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Injectable Anticoagulants Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Injectable Anticoagulants Revenue by Type (2017-2022)
8.4 Asia-Pacific Injectable Anticoagulants Revenue by Application (2017-2022)
9 Europe
9.1 Europe Injectable Anticoagulants Market Size YoY Growth 2017-2028
9.2 Europe Injectable Anticoagulants Market Facts & Figures by Country (2017-2028)
9.3 Europe Injectable Anticoagulants Revenue by Type (2017-2022)
9.4 Europe Injectable Anticoagulants Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Injectable Anticoagulants Market Size YoY Growth 2017-2028
10.2 Latin America Injectable Anticoagulants Market Facts & Figures by Country (2017-2028)
10.3 Latin America Injectable Anticoagulants Revenue by Type (2017-2022)
10.4 Latin America Injectable Anticoagulants Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Injectable Anticoagulants Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Injectable Anticoagulants Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Injectable Anticoagulants Revenue by Type (2017-2022)
11.4 Middle East and Africa Injectable Anticoagulants Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Injectable Anticoagulants Supply Chain Analysis
12.2 Injectable Anticoagulants Key Raw Materials and Upstream Suppliers
12.3 Injectable Anticoagulants Clients Analysis
12.4 Injectable Anticoagulants Sales Channel and Sales Model Analysis
12.4.1 Injectable Anticoagulants Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Injectable Anticoagulants Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Injectable Anticoagulants Distributors
13 Market Dynamics
13.1 Injectable Anticoagulants Industry Trends
13.2 Injectable Anticoagulants Market Drivers
13.3 Injectable Anticoagulants Market Challenges
13.4 Injectable Anticoagulants Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Injectable Anticoagulants Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Low-Molecular-Weight Heparin (LMWH)
Table 3. Major Companies of Direct Thrombin Inhibitor (DTI)
Table 4. Major Companies of Others
Table 5. Global Injectable Anticoagulants Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Injectable Anticoagulants Market Size by Region (US$ Million): 2022 VS 2028
Table 7. Global Injectable Anticoagulants Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Injectable Anticoagulants Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 9. Injectable Anticoagulants Revenue by Company (2017-2022) & (US$ Million)
Table 10. Injectable Anticoagulants Revenue Share by Company (2017-2022)
Table 11. Ranking of Global Top Injectable Anticoagulants Players by Revenue (US$ Million) in 2021
Table 12. Global Injectable Anticoagulants Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 13. Global Injectable Anticoagulants by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Injectable Anticoagulants as of 2021)
Table 14. Global Injectable Anticoagulants Companies Headquarters
Table 15. Global Injectable Anticoagulants Companies Product & Service
Table 16. Date of International Companies Enter into Injectable Anticoagulants Market
Table 17. Global Injectable Anticoagulants Mergers & Acquisitions, Expansion Plans
Table 18. Sanofi Corporation Information
Table 19. Sanofi Description and Business Overview
Table 20. Sanofi Injectable Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 21. Sanofi Injectable Anticoagulants Product
Table 22. Sanofi Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Product in 2021
Table 23. Sanofi Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Application in 2021
Table 24. Sanofi Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Geographic Area in 2021
Table 25. Sanofi Recent Development
Table 26. Genentech (Roche) Corporation Information
Table 27. Genentech (Roche) Description and Business Overview
Table 28. Genentech (Roche) Injectable Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 29. Genentech (Roche) Injectable Anticoagulants Product
Table 30. Genentech (Roche) Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Product in 2021
Table 31. Genentech (Roche) Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Application in 2021
Table 32. Genentech (Roche) Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Geographic Area in 2021
Table 33. Genentech (Roche) Recent Development
Table 34. Boehringer Ingelheim Corporation Information
Table 35. Boehringer Ingelheim Description and Business Overview
Table 36. Boehringer Ingelheim Injectable Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 37. Boehringer Ingelheim Injectable Anticoagulants Product
Table 38. Boehringer Ingelheim Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Product in 2021
Table 39. Boehringer Ingelheim Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Application in 2021
Table 40. Boehringer Ingelheim Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Geographic Area in 2021
Table 41. Boehringer Ingelheim Recent Development
Table 42. Pfizer Corporation Information
Table 43. Pfizer Description and Business Overview
Table 44. Pfizer Injectable Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 45. Pfizer Injectable Anticoagulants Product
Table 46. Pfizer Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Product in 2021
Table 47. Pfizer Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Application in 2021
Table 48. Pfizer Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Geographic Area in 2021
Table 49. Pfizer Recent Development
Table 50. The Medicines Company Corporation Information
Table 51. The Medicines Company Description and Business Overview
Table 52. The Medicines Company Injectable Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 53. The Medicines Company Injectable Anticoagulants Product
Table 54. The Medicines Company Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Product in 2021
Table 55. The Medicines Company Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Application in 2021
Table 56. The Medicines Company Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Geographic Area in 2021
Table 57. The Medicines Company Recent Development
Table 58. Aspen Corporation Information
Table 59. Aspen Description and Business Overview
Table 60. Aspen Injectable Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 61. Aspen Injectable Anticoagulants Product
Table 62. Aspen Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Product in 2021
Table 63. Aspen Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Application in 2021
Table 64. Aspen Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Geographic Area in 2021
Table 65. Otsuka Corporation Information
Table 66. Otsuka Description and Business Overview
Table 67. Otsuka Injectable Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 68. Otsuka Injectable Anticoagulants Product
Table 69. Otsuka Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Product in 2021
Table 70. Otsuka Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Application in 2021
Table 71. Otsuka Injectable Anticoagulants Revenue Proportion of Injectable Anticoagulants by Geographic Area in 2021
Table 72. Global Injectable Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 73. Global Injectable Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 74. Global Injectable Anticoagulants Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 75. North America Injectable Anticoagulants Revenue by Country (2017-2022) & (US$ Million)
Table 76. North America Injectable Anticoagulants Revenue by Country (2023-2028) & (US$ Million)
Table 77. North America Injectable Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 78. North America Injectable Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia-Pacific Injectable Anticoagulants Revenue by Region (2017-2028) & (US$ Million)
Table 80. Asia-Pacific Injectable Anticoagulants Revenue by Region (2023-2028) & (US$ Million)
Table 81. Asia-Pacific Injectable Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 82. Asia-Pacific Injectable Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 83. Europe Injectable Anticoagulants Revenue by Country (2017-2022) & (US$ Million)
Table 84. Europe Injectable Anticoagulants Revenue by Country (2023-2028) & (US$ Million)
Table 85. Europe Injectable Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 86. Europe Injectable Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 87. Latin America Injectable Anticoagulants Revenue by Country (2017-2022) & (US$ Million)
Table 88. Latin America Injectable Anticoagulants Revenue by Country (2023-2028) & (US$ Million)
Table 89. Latin America Injectable Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 90. Latin America Injectable Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 91. Middle East and Africa Injectable Anticoagulants Revenue by Country (2017-2022) & (US$ Million)
Table 92. Middle East and Africa Injectable Anticoagulants Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Injectable Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 94. Middle East and Africa Injectable Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 95. Injectable Anticoagulants Key Raw Materials, Industry Status and Trend
Table 96. Injectable Anticoagulants Key Raw Materials and Upstream Suppliers
Table 97. Injectable Anticoagulants Clients Status and Trend
Table 98. Injectable Anticoagulants Typical Clients
Table 99. Injectable Anticoagulants Distributors
Table 100. Injectable Anticoagulants Market Trends
Table 101. Injectable Anticoagulants Market Drivers
Table 102. Injectable Anticoagulants Market Challenges
Table 103. Injectable Anticoagulants Market Restraints
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Injectable Anticoagulants Product Picture
Figure 2. Global Injectable Anticoagulants Revenue Market Share by Type in 2021 & 2028
Figure 3. Low-Molecular-Weight Heparin (LMWH) Product Picture
Figure 4. Direct Thrombin Inhibitor (DTI) Product Picture
Figure 5. Others Product Picture
Figure 6. Global Injectable Anticoagulants Revenue Market Share by Application in 2021 & 2028
Figure 7. VTE
Figure 8. ACS/MI
Figure 9. AF
Figure 10. Others
Figure 11. Injectable Anticoagulants Report Years Considered
Figure 12. Global Injectable Anticoagulants Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Injectable Anticoagulants Market Size 2017-2028 (US$ Million)
Figure 14. Global Injectable Anticoagulants Market Size Market Share by Region: 2022 Versus 2028
Figure 15. Global Injectable Anticoagulants Revenue Market Share by Region (2017-2028)
Figure 16. Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Injectable Anticoagulants Revenue Market Share Forecast by Type (2017-2028)
Figure 18. Global Injectable Anticoagulants Revenue Market Share Forecast by Application (2017-2028)
Figure 19. North America Injectable Anticoagulants Revenue 2017-2028 (US$ Million)
Figure 20. North America Injectable Anticoagulants Revenue Market Share by Type (2017-2022)
Figure 21. North America Injectable Anticoagulants Revenue Market Share by Application (2017-2022)
Figure 22. Asia-Pacific Injectable Anticoagulants Revenue 2017-2028 (US$ Million)
Figure 23. Asia-Pacific Injectable Anticoagulants Revenue Market Share by Region (2017-2028)
Figure 24. Asia-Pacific Injectable Anticoagulants Revenue Market Share by Type (2017-2022)
Figure 25. Asia-Pacific Injectable Anticoagulants Revenue Market Share by Application (2017-2022)
Figure 26. Europe Injectable Anticoagulants Revenue Growth Rate 2017-2028 (US$ Million)
Figure 27. Europe Injectable Anticoagulants Revenue Market Share by Country (2017-2028)
Figure 28. Europe Injectable Anticoagulants Revenue Market Share by Type (2017-2022)
Figure 29. Europe Injectable Anticoagulants Revenue Market Share by Application (2017-2022)
Figure 30. Latin America Injectable Anticoagulants Revenue Growth Rate 2017-2028 (US$ Million)
Figure 31. Latin America Injectable Anticoagulants Revenue Market Share by Country (2017-2022)
Figure 32. Latin America Injectable Anticoagulants Revenue Market Share by Type (2017-2022)
Figure 33. Latin America Injectable Anticoagulants Revenue Market Share by Application (2017-2022)
Figure 34. Middle East and Africa Injectable Anticoagulants Revenue Growth Rate 2017-2028 (US$ Million)
Figure 35. Middle East and Africa Injectable Anticoagulants Revenue Market Share by Country (2017-2028)
Figure 36. Middle East and Africa Injectable Anticoagulants Revenue Market Share by Type (2017-2022)
Figure 37. Middle East and Africa Injectable Anticoagulants Revenue Market Share by Application (2017-2022)
Figure 38. Injectable Anticoagulants Supply Chain (Upstream and Downstream Market)
Figure 39. Global Production Market Share of Injectable Anticoagulants Raw Materials by Region in 2021
Figure 40. Injectable Anticoagulants Distribution Channels
Figure 41. Global Injectable Anticoagulants Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 42. Global Injectable Anticoagulants Percentage 2017-2028: Online Sales VS Offline Sales
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
  • Global Fibrinogen Concentrate Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......
  • Global Fibrinogen Concentrate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91
    According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......
  • Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124
    Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......
  • Global Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......
  • Global Low Molecular Weight Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......
  • Global Heparin Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......
  • Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......
  • Global Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs